He will support efforts to take New Jersey's drug cost caps to the national level.

Herbert C. Conaway, Jr. · New Jersey · Democratic

policy impact 0.84 specificity 0.83 extraction confidence 95%

Commitment kind: unknown. Promised action: not established. Promised outcome: not established. Deadline: unknown; not assumed expired.

Occurrences

Because these issues are so dear to my heart, I will support efforts that take New Jersey’s life-saving drug cost caps to the national level.

Promises to back federal prescription drug cost-cap efforts modeled on New Jersey policy.

Issues | Herb Conaway
campaign · campaign_site · model gpt-5.4-mini

Evidence

legacy_unverified · Source version not recorded · locator unknown

Sponsor: Rep. Conaway, Herbert C. [D-NJ-3] (Introduced 11/10/2025). Committees: House - Veterans' Affairs. Latest Action: House - 01/13/2026 Subcommittee Hearings Held. Committee activity is listed for 11/10/2025 referral, 11/17/2025 referral to the Subcommittee on Health, and 01/13/2026 hearings by the subcommittee.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Conaway advanced a veterans bill into subcommittee hearings, but it is not a prescription-drug cost-cap measure; the bill remains introduced and unpassed.

unresolved same_term A for effort

H.R.5999 - Committees | Congress.gov
secondary · model gpt-5.4-mini · confidence 78%

legacy_unverified · Source version not recorded · locator unknown

Committee on Veterans’ Affairs: Full Committee held a markup on H.R. 5999, the 'Veteran Opioid Emergency Treatment Act' ... H.R. 5999 was ordered reported, as amended.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Within the lookback window, Conaway's bill moved through committee markup and was ordered reported, but the recorded measure is an opioid-antagonist access bill rather than a national prescription drug cost-cap bill.

unresolved same_term A for effort

CREC-2026-05-14-pt1-PgD513-2.pdf
secondary · model gpt-5.4-mini · confidence 83%

legacy_unverified · Source version not recorded · locator unknown

Congress.gov's member page for Herbert C. Conaway, Jr. shows no matches for "drug," "price," "cost," "cap," "insulin," or "prescription drug" on the page search, and the only prescription-related sponsored bill surfaced is H.R.5999, whose latest action is listed as House - 01/13/2026 Subcommittee Hearings Held. That points to no documented national drug-cost-cap effort in the lookback window.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Official congressional records do not show a June 22-24, 2026 drug-cost-cap action by Conaway; the closest visible activity is an unrelated opioid-antagonist access bill.

unresolved same_term

Herbert C. Conaway, Jr. | Congress.gov | Library of Congress
primary · model gpt-5.4-mini · confidence 90%

Assessments

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): unresolved. unknown

Official congressional records in the provided evidence do not show Herbert C. Conaway, Jr. advancing New Jersey-style drug cost caps to the national level. The only documented legislative activity is an unrelated veterans opioid-access bill, which is not the promised policy. That is insufficient to mark the promise delivered or even partially delivered on the specific claim.

provider codex_cli · model gpt-5.4-mini · confidence 88%

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): unresolved. unknown

The provided evidence shows Conaway sponsored or advanced H.R. 5999, a veterans opioid emergency treatment/opioid-antagonist access measure, not a national prescription drug cost-cap bill modeled on New Jersey's drug cost caps. There is no evidence in the payload that he supported, sponsored, voted for, or materially advanced a federal drug cost-cap effort, and no evidence that such a national cap was enacted. Because the relevant promise-specific evidence is missing rather than clearly disproving any attempt, the claim remains unresolved rather than delivered or never.

provider codex_cli · model gpt-5.5 · confidence 78%